Up a level |
Hykin, Philip, Prevost, A Toby, Vasconcelos, Joana C, Murphy, Caroline, Kelly, Joanna, Ramu, Jayashree, Hounsome, Barry, Yang, Yit, Harding, Simon P ORCID: 0000-0003-4676-1158, Lotery, Andrew et al (show 63 more authors)
(2019)
Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion A Randomized Clinical Trial.
JAMA OPHTHALMOLOGY, 137 (11).
pp. 1256-1264.
Chorev, Michal, Haderlein, Jonas, Chandra, Shruti, Menon, Geeta, Burton, Benjamin JL, Pearce, Ian, McKibbin, Martin, Thottarath, Sridevi, Karatsai, Eleni, Chandak, Swati et al (show 12 more authors)
(2023)
A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1.
JOURNAL OF CLINICAL MEDICINE, 12 (8).
3013-.
Pearce, Ian, Amoaku, Winfried, Bailey, Clare, Downey, Louise, Gale, Richard, Ghanchi, Faruque, Hamilton, Robin, Mahmood, Sajjad, Menon, Geeta, Nosek, Jenny et al (show 2 more authors)
(2022)
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice.
EYE, 36 (9).
pp. 1725-1734.